Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

HeartSciences (HSCS) Return on Sales (2021 - 2026)

HeartSciences (HSCS) has disclosed Return on Sales for 5 consecutive years, with 972.69% as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Return on Sales fell 99057.0% year-over-year to 972.69%, compared with a TTM value of 25.46% through Oct 2025, down 3630.0%, and an annual FY2025 reading of 2035.18%, down 167712.0% over the prior year.
  • Return on Sales was 972.69% for Q4 2025 at HeartSciences, up from 1083.06% in the prior quarter.
  • Across five years, Return on Sales topped out at 377.11% in Q2 2024 and bottomed at 1234.2% in Q2 2023.
  • Average Return on Sales over 5 years is 364.01%, with a median of 448.3% recorded in 2023.
  • The sharpest move saw Return on Sales skyrocketed 161132bps in 2024, then plummeted -117620bps in 2025.
  • Year by year, Return on Sales stood at 100.49% in 2021, then crashed by -558bps to 661.67% in 2022, then surged by 32bps to 448.3% in 2023, then skyrocketed by 104bps to 17.88% in 2024, then tumbled by -5540bps to 972.69% in 2025.
  • Business Quant data shows Return on Sales for HSCS at 972.69% in Q4 2025, 1083.06% in Q3 2025, and 11.62% in Q2 2025.